Bone morphogenetic protein-4 control of pituitary pathophysiology

Frontiers of Hormone Research

Volumn 35, Issue , 2006, Pages 22-31

  Giacomini, Damiana ^a   Páez Pereda, Marcelo ^c   Theodoropoulou, Marily ^b   Gerez, Juan ^a   Nagashima, Alberto Carbia ^a   Chervin, Alberto ^d   Berner, Silvia ^d   Labeur, Marta ^b   Refojo, Damian ^a   Renner, Ulrich ^b   Stalla, Günter K ^b   Arzt, Eduardo ^a  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c Affectis Pharmaceutical AG   (Germany)

^d Hospital Oftalmologico Santa Lucia   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; CORTICOTROPIN; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL; BIOLOGICAL MODEL; CONFERENCE PAPER; CYTOLOGY; GENE EXPRESSION; GROWTH, DEVELOPMENT AND AGING; HUMAN; HYPOPHYSIS; HYPOPHYSIS DISEASE; METABOLISM; NERVE CELL; PHYSIOLOGY; SECRETION;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BONE MORPHOGENETIC PROTEINS; GENE EXPRESSION; HUMANS; MODELS, BIOLOGICAL; NEURONS; PITUITARY DISEASES; PITUITARY GLAND; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN;

EID: 33745802641     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000094262     Document Type: Conference Paper

References (42)

1. Massague J: TGF-beta signal transduction. Annu Rev Biochem 1998;67:753-791.
2. Massague J: How cells read TGF-beta signals. Nat Rev Mol Cell Biol 2000;1:169-178.
3. Shi Y, Massague J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003;113:685-700.
4. Massague J, Chen YG: Controlling TGF-beta signaling. Genes Dev 2000;14:627-644.
5. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA: Novel regulators of bone formation: molecular clones and activities. Science 1988;242:1528-1534.
6. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S: Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991;113:681-687.
7. Duprez DM, Coltey M, Amthor H, Brickell PM, Tickle C: Bone morphogenetic protein-2 (BMP-2) inhibits muscle development and promotes cartilage formation in chick limb bud cultures. Dev Biol 1996;174:448-452.
8. Bellusci S, Henderson R, Winnier G, Oikawa T, Hogan BL: Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development 1996;122:1693-1702.
9. Hogan BL, Blessing M, Winnier GE, Suzuki N, Jones CM: Growth factors in development: the role of TGF-beta related polypeptide signalling molecules in embryogenesis. Dev Suppl 1994:53-60.
10. Winnier G, Blessing M, Labosky PA, Hogan BL: Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995;9:2105-2116.
11. Jones CM, Lyons KM, Hogan BLM: Involvement of bone morphogenetic protein (Bmp-4) and Vgr-1 in morphogenesis and neurogenesis in mouse. Development 1991;111:531-542.
12. Wilson PA, Hemmati-Brivanlou A: Induction of epidermis and inhibition of neural fate by Bmp-4. Nature 1995;376:331-333.
13. Harland RM: Neural induction in Xenopus. Curr Opin Genet Dev 1994;4:543-549.
14. Hawley SH, Wunnenberg-Stapleton K, Hashimoto C, Laurent MN, Watabe T, Blumberg BW, Cho KWY: Disruption of BMP signals in embryonic Xenopus ectoderm leads to direct neural induction. Genes Dev 1995;9:2923-2935.
15. Lamb TM, Knecht AK, Smith WC, Stachel SE, Economides AN, Stahl N, Yancopolous GD, Harland RM: Neural induction by the secreted polypeptide noggin. Science 1993;262:713-718.
16. Sasai Y, Lu B, Steinbeisser H, De Robertis EM: Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning signals in Xenopus. Nature 1995;377:757.
17. Rossi JM, Dunn NR, Hogan BL, Zaret KS: Distinct mesodermal signals, including BMPs from septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev 2001;15:1998-2009.
18. Dudley AT, Lyons KM, Robertson EJ: A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 1995;9:2795-2807.
19. Roberts DJ, Johnson RL, Burke AC, Nelson CE, Morgan BA, Tabin C: Sonic hedgehog is an endodermal signal inducing Bmp-4 and Hox genes during induction and regionalization of the chick hindgut. Development 1995;121:3163-3174.
20. Scully KM, Rosenfeld MG: Pituitary development: regulatory codes in mammalian organogenesis. Science 2002;295:2231-2235.
21. Dasen JS, Rosenfeld MG: Signaling mechanisms in pituitary morphogenesis and cell fate determination. Curr Opin Cell Biol 1999;11:669-677.
22. Dasen JS, Rosenfeld MG: Signaling and transcriptional mechanisms in pituitary development. Annu Rev Neurosci 2001;24:327-355.
23. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG: Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 1998;12: 1691-1704.
24. Kioussi C, Carriere C, Rosenfeld MG: A model for the development of the hypothalamic-pituitary axis: transcribing the hypophysis. Mech Dev 1999;81:23-35.
25. Kioussi C, O'Connell S, St-Onge L, Treier M, Gleiberman AS, Gruss P, Rosenfeld MG: Pax6 is essential for establishing ventral-dorsal cell boundaries in pituitary gland development. Proc Natl Acad Sci USA 1999;96:14378-14382.
26. Paez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, Grubler Y, Chervin A, Goldberg V, Goya R, Hentges ST, Low MJ, Holsboer F, Stalla GK, Arzt E: Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci USA 2003;100:1034-1039.
27. Karsenty G: The genetic transformation of bone biology. Genes Dev 1999;13:3037-3051.
28. Massague J, Blain SW, Lo RS: TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000;103:295-309.
29. Matsuda T, Yamamoto T, Muraguchi A, Saatcioglu F: Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J Biol Chem 2001;276:42908-42914.
30. Giacomini D, Paez-Pereda M, Theodoropoulou M, Labeur M, Refojo D, Gerez J, Chervin A, Berner S, Losa M, Buchfelder M, Renner U, Stalla GK, Arzt E: Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology 2006;147:247-256.
31. Nudi M, Ouimette JF, Drouin J: Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity. Mol Endocrinol 2005;19:1329-1342.
32. Hentges S, Sarkar DK: Transforming growth factor-beta regulation of estradiol-induced prolactinomas. Front Neuroendocrinol 2001;22:340-363.
33. Sheng HZ, Moriyama K, Yamashita T, Li H, Potter SS, Mahon KA, Westphal H: Multistep control of pituitary organogenesis. Science 1997;278:1809-1812.
34. Páez-Pereda M, Kovalovsky D, Hopfner U, Theodoropoulou M, Pagotto U, Uhl E, Losa M, Stalla J, Grubler Y, Missale C, Arzt E, Stalla G: Retinoic acid prevents experimental Cushing syndrome. J Clin Invest 2001;108:1123-1131.
35. Tran P, Zhang XK, Salbert G, Hermann T, Lehmann JM, Pfahl M: COUP orphan receptors are negative regulators of retinoic acid response pathways. Mol Cell Biol 1992;12:4666-4676.
36. Kliewer SA, Umesono K, Heyman RA, Mangelsdorf DJ, Dyck JA, Evans RM: Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling. Proc Natl Acad Sci USA 1992;89: 1448-1452.
37. Wu Q, Li Y Liu R, Agadir A, Lee MO, Liu Y, Zhang X: Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J 1997;16:1656-1669.
38. Beland M, Lohnes D: Chicken ovalbumin upstream promoter-transcription factor members repress retinoic acid-induced Cdxl expression. J Biol Chem 2005;280:13858-13862.
39. Kang HY, Huang KE, Chang SY, Ma WL, Lin WJ, Chang C: Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J Biol Chem 2002;277:43749-43756.
40. Skillington J, Choy L, Derynck R: Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol 2002;159:135-146.
41. Sumantran VN, Brederlau A, Funa K: BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells. Anticancer Res 2003;23:1297-1303.
42. Li X, Schwarz EM, Zuscik MJ, Rosier RN, Ionescu AM, Puzas JE, Drissi H, Sheu TJ, O'Keefe RJ: Retinoic acid stimulates chondrocyte differentiation and enhances bone morphogenetic protein effects through induction of Smad1 and Smad5. Endocrinology 2003;144:2514-2523.